Citigroup Lowers Owens & Minor (NYSE:OMI) Price Target to $18.50

Owens & Minor (NYSE:OMI - Free Report) had its price objective trimmed by Citigroup from $21.00 to $18.50 in a research note released on Tuesday, Benzinga reports. The firm currently has a buy rating on the stock.

A number of other research analysts also recently issued reports on OMI. StockNews.com downgraded shares of Owens & Minor from a "buy" rating to a "hold" rating in a research report on Monday, August 26th. Barclays cut their price objective on shares of Owens & Minor from $18.00 to $14.00 and set an "equal weight" rating on the stock in a report on Tuesday. Robert W. Baird lowered their target price on shares of Owens & Minor from $19.00 to $14.00 and set a "neutral" rating for the company in a report on Tuesday. Finally, JPMorgan Chase & Co. cut their price target on Owens & Minor from $22.00 to $18.00 and set an "underweight" rating on the stock in a research note on Wednesday, August 21st. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat, Owens & Minor has a consensus rating of "Hold" and a consensus target price of $18.50.

Owens & Minor Price Performance

Shares of OMI traded down $0.22 during mid-day trading on Tuesday, hitting $11.78. 1,273,269 shares of the company traded hands, compared to its average volume of 834,960. The company has a current ratio of 1.09, a quick ratio of 0.51 and a debt-to-equity ratio of 2.17. The stock has a market capitalization of $908.24 million, a price-to-earnings ratio of -21.04, a PEG ratio of 0.43 and a beta of 0.41. The business has a 50-day moving average of $14.54 and a 200 day moving average of $16.19. Owens & Minor has a one year low of $11.42 and a one year high of $28.35.

Owens & Minor (NYSE:OMI - Get Free Report) last announced its quarterly earnings data on Monday, November 4th. The company reported $0.42 EPS for the quarter, beating analysts' consensus estimates of $0.41 by $0.01. The firm had revenue of $2.72 billion for the quarter, compared to analyst estimates of $2.68 billion. Owens & Minor had a positive return on equity of 14.66% and a negative net margin of 0.40%. The business's quarterly revenue was up 5.0% compared to the same quarter last year. During the same period last year, the company earned $0.44 EPS. As a group, equities analysts expect that Owens & Minor will post 1.57 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in OMI. Vanguard Group Inc. raised its position in shares of Owens & Minor by 1.9% during the first quarter. Vanguard Group Inc. now owns 8,749,866 shares of the company's stock worth $242,459,000 after purchasing an additional 162,182 shares during the period. Deerfield Management Company L.P. Series C raised its holdings in Owens & Minor by 30.6% during the 2nd quarter. Deerfield Management Company L.P. Series C now owns 6,371,440 shares of the company's stock worth $86,014,000 after buying an additional 1,493,852 shares during the period. Gabelli Funds LLC lifted its stake in Owens & Minor by 25.9% in the first quarter. Gabelli Funds LLC now owns 170,000 shares of the company's stock valued at $4,711,000 after buying an additional 35,000 shares in the last quarter. Renaissance Technologies LLC boosted its holdings in shares of Owens & Minor by 16.5% in the second quarter. Renaissance Technologies LLC now owns 1,246,600 shares of the company's stock valued at $16,829,000 after buying an additional 176,250 shares during the period. Finally, Dimensional Fund Advisors LP increased its position in shares of Owens & Minor by 1.7% during the second quarter. Dimensional Fund Advisors LP now owns 4,534,204 shares of the company's stock worth $61,213,000 after acquiring an additional 76,599 shares in the last quarter. 98.04% of the stock is owned by institutional investors and hedge funds.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.